Natural Killer (NK) cells play a crucial role in innate immunity by identifying and eliminating aberrant cells. The recent achievements in chimeric antigen receptor (CAR) T cell therapy have opened avenues for the potential engineering of NK cells as innovative immune therapeutics. In an upcoming webinar, Dean A. Lee will explore the benefits of CAR NK cell therapy and provide insights into the most recent advancements in their clinical applicability.
